| |
| | AATOD: AATOD's Policies |
 | | The focus here is on minimizing the potential for cardiac electrical conduction disturbances being caused by LAAM in patients attending opioid agonist treatment (OAT) programs regulated by CSAT. |
 | | These would include diuretics, laxatives, and supraphysiological use of steroid hormones with mineralocorticoid potential, as well as alcohol intake at a level to cause significant fluid and electrolyte disturbance. |
 | | These would include diuretics, laxatives, and supraphysiological use of steroid hormones with mineralocorticoid potential, as well as alcohol intake at a level to cause significant fluid and electrolyte disturbance (personal communication, Gregory Hicks, PharmD, Roxane Laboratories, Inc., October 28, 2001; also in ORLAAM PI, 2001). |
| www.aatod.org /policy_clinical.html (1340 words) |
|